151 related articles for article (PubMed ID: 11362210)
1. Triple combination superior to double combination.
Grodeck B
Posit Aware; 1995; ():6. PubMed ID: 11362210
[TBL] [Abstract][Full Text] [Related]
2. 3TC/AZT: just another combination.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
[TBL] [Abstract][Full Text] [Related]
3. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
James JS
AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy increases survival.
Treat Rev; 1995 Nov; (no 20):2-3. PubMed ID: 11363019
[TBL] [Abstract][Full Text] [Related]
5. AZT studies reinforce benefits of combination.
AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
[TBL] [Abstract][Full Text] [Related]
6. Studies confirm value of early and combination treatments.
Vazquez E
Posit Aware; 1995; VI(6):8. PubMed ID: 11363148
[TBL] [Abstract][Full Text] [Related]
7. New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
James JS
AIDS Treat News; 1995 Dec; (no 236):7. PubMed ID: 11363052
[TBL] [Abstract][Full Text] [Related]
8. Lamivudine (3TC) approved for combination use with AZT.
James JS
AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
[TBL] [Abstract][Full Text] [Related]
9. AZT plus 3TC produces best results to date.
Grodeck B
Posit Aware; 1995; ():6. PubMed ID: 11362209
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine triple combo results released.
Common Factor; 1995 Apr; (no 10):21. PubMed ID: 11362346
[TBL] [Abstract][Full Text] [Related]
11. New combo trial/same old style.
Gilden D
GMHC Treat Issues; 1995 Apr; 9(4):9. PubMed ID: 11362369
[TBL] [Abstract][Full Text] [Related]
12. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
13. Study results at a glance.
AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
[TBL] [Abstract][Full Text] [Related]
14. ACTG 175 and Delta.
Torres G
GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
[TBL] [Abstract][Full Text] [Related]
15. Merck protease inhibitor: more news from Retroviruses Conference.
James JS
AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186
[TBL] [Abstract][Full Text] [Related]
16. Combination 3TC/AZT therapy shows promise.
AIDS Clin Care; 1995 Mar; 7(3):22. PubMed ID: 11362192
[TBL] [Abstract][Full Text] [Related]
17. Another option for less than 50 T4 cells.
Treat Rev; 1995; (no 19):3. PubMed ID: 11362755
[TBL] [Abstract][Full Text] [Related]
18. 3TC: combination trial stopped early as clinical benefit shown.
James JS
AIDS Treat News; 1996 Aug; (no 252):5. PubMed ID: 11363752
[TBL] [Abstract][Full Text] [Related]
19. 3TC approval may revive AZT's appeal.
Vazquez E
Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitors shine in triple combinations.
AIDS Alert; 1996 Mar; 11(3):31-2. PubMed ID: 11363243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
